Akita Spontaneously Type 1 Diabetic Mice Exhibit Elevated Vascular Arginase and Impaired Vascular Endothelial and Nitrergic Function-Reference-Cited by-同舟云学术

Akita Spontaneously Type 1 Diabetic Mice Exhibit Elevated Vascular Arginase and Impaired Vascular Endothelial and Nitrergic Function

Published:2013-08-19 Issue:8 Volume:8 Page:e72277
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Toque Haroldo A.,Nunes Kenia P.,Yao Lin,Xu Zhimin,Kondrikov Dmitry,Su Yunchao,Webb R. Clinton,Caldwell Ruth B.,Caldwell R. William

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference52 articles.

1. Arginase: a critical regulator of nitric oxide synthesis and vascular function;W Durante;Clin Exp Pharmacol Physiol,2007

2. Contractile responses in spontaneously diabetic mice. I. Involvement of superoxide anion in enhanced contractile response of aorta to norepinephrine in C57BL/KsJ (db/db) mice;N Kanie;Gen Pharmacol,2000

3. Alterations in EDHF-type relaxation and phosphodiesterase activity in mesenteric arteries from diabetic rats;T Matsumoto;Am J Physiol Heart Circ Physiol,2003

4. Endothelial dysfunction in the early- and late-stage type-2 diabetic Goto-Kakizaki rat aorta;E Kazuyama;Mol Cell Biochem,2009

5. Endothelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature;C Nacci;Endocrinology,2009

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of neutrophil extracellular trap formation alleviates vascular dysfunction in type 1 diabetic mice;Science Advances;2023-10-27

2. An Engineered Nanosugar Enables Rapid and Sustained Glucose‐Responsive Insulin Delivery in Diabetic Mice;Advanced Materials;2023-03-12

3. Arginase: Biological and Therapeutic Implications in Diabetes Mellitus and Its Complications;Oxidative Medicine and Cellular Longevity;2022-10-26

4. Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options;Biomedicines;2022-09-14

5. Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes;International Journal of Molecular Sciences;2022-07-19